𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial

✍ Scribed by Jay R. Lieberman; Nadia Rosencher; Frank Misselwitz


Book ID
113468262
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
20 KB
Volume
24
Category
Article
ISSN
1532-8406

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES